Key publications

Cathelicidin is a “fire alarm”, generating protective NLRP3-dependent airway epithelial cell inflammatory responses during infection with Pseudomonas aeruginosa
12 Apr 2019 in PLoS Pathogens, vol. 15
DOI: https://doi.org/10.1371/journal.ppat.1007694
Research output: Contribution to Journal › Article (Published)

Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy
1 May 2019 in OncoImmunology, pp. 1-17
DOI: https://doi.org/10.1080/2162402X.2019.1608106
Research output: Contribution to Journal › Article (E-pub ahead of print)

Antimicrobial host defence peptides: functions and clinical potential
27 Feb 2020 in Nature Reviews Drug Discovery
DOI: https://doi.org/10.1038/s41573-019-0058-8
Research output: Contribution to Journal › Review article (Published)

The neutrophil antimicrobial peptide cathelicidin promotes Th17 differentiation
24 Feb 2021 in Nature Communications
DOI: https://doi.org/10.1038/s41467-021-21533-5
Research output: Contribution to Journal › Article (Published)

The antimicrobial peptide cathelicidin drives development of experimental autoimmune encephalomyelitis in mice by affecting Th17 differentiation
26 Aug 2022 in PLoS Biology
DOI: https://doi.org/10.1371/journal.pbio.3001554
Research output: Contribution to Journal › Article (Published)

View all 93 publications on Research Explorer

Data last updated: 05/06/2023 at 12:13